Top Markets
#1 Pleasing Gold Pleasing Gold +1,557.08%
#2 PulseChain PulseChain +55.72%
#3 DogBull DogBull +37.22%
#4 Ontology Gas Ontology Gas +35.76%
#5 BOOK OF MEME BOOK OF MEME +31.40%
#6 Collect on Fanable Collect on Fanable +24.33%
#7 Neiro Neiro +20.73%
#8 Pump.fun Pump.fun +18.66%
#9 Unit Pump Unit Pump +18.66%
#10 Cryptopia Cryptopia +17.74%
Coin of the day
Pleasing Gold Pleasing Gold
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Enimmune corporation Enimmune corporation

Enimmune corporation

6564
Kedudukan dalam Saham #26781
Enimmune Corporation is a Taiwanese biopharmaceutical company primarily focused... Enimmune Corporation is a Taiwanese biopharmaceutical company primarily focused on the research, development, and commercialization of pharmaceutical products. Among its key offerings is Tuberculin PPD RT23 SSI, an approved diagnostic agent utilized in tuberculin tests to ascertain the presence of tuberculosis infection in patients. Beyond its existing products, Enimmune is heavily invested in developing vaccines aimed at combating a diverse array of infectious diseases. These include, but are not limited to, vaccines for enterovirus, pneumonia, norovirus, dengue fever, and Middle East Respiratory Syndrome Coronavirus (MERS-CoV). Established in 2014, the company maintains its headquarters in Taichung City, Taiwan.
Harga Saham
$0.52468396
Modal Pasaran
$37.85M
Perubahan (1 hari)
1.23%
Perubahan (1 tahun)
-4.53%
Negara
TW
Perdagangan Enimmune corporation (6564)

Kategori

Healthcare
Hasil untuk Enimmune corporation (6564)
Hasil pada Aug 2026 TTM: 0
Menurut laporan kewangan terkini daripada Enimmune corporation, hasil semasa syarikat (TTM) ialah 0. Pada tahun 2026, syarikat memperoleh hasil sebanyak 0 sama dengan hasil pada tahun 2026 iaitu 0. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi Enimmune corporation dari 2026 hingga 2026
Hasil pada akhir setiap tahun
Tahun Hasil Ubah
Tidak cukup data untuk tarikh yang disediakan.
Hasil untuk syarikat atau pesaing serupa
Syarikat Hasil Perbezaan Hasil Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH